154 related articles for article (PubMed ID: 33330055)
1. Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs.
Wen J; Wang Y; Luo L; Peng L; Chen C; Guo J; Ge Y; Li W; Jin X
Front Oncol; 2020; 10():578809. PubMed ID: 33330055
[TBL] [Abstract][Full Text] [Related]
2. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
Xu S; Wang Z; Ye J; Mei S; Zhang J
Front Oncol; 2021; 11():729103. PubMed ID: 34568059
[TBL] [Abstract][Full Text] [Related]
3. Construction of 11 metabolic-related lncRNAs to predict the prognosis in lung adenocarcinoma.
Jiang W; Xu Z; Huang L; Qin F; Yuan L; Sun Y; Qin J; Deng K; Zheng T; Long X; Li S
BMC Med Genomics; 2023 Dec; 16(1):330. PubMed ID: 38110999
[TBL] [Abstract][Full Text] [Related]
4. Identification and verification on prognostic index of glioblastoma immune-related lncRNAs.
Zheng G; Jiang Q; Jiang C; Zhu X; Wang Y
Adv Clin Exp Med; 2024 Feb; ():. PubMed ID: 38376452
[TBL] [Abstract][Full Text] [Related]
5. The Comprehensive Analysis of m6A-Associated Anoikis Genes in Low-Grade Gliomas.
Zheng H; Zhao Y; Zhou H; Tang Y; Xie Z
Brain Sci; 2023 Sep; 13(9):. PubMed ID: 37759912
[TBL] [Abstract][Full Text] [Related]
6. Development of an m6A-Related lncRNAs Signature Predicts Tumor Stemness and Prognosis for Low-Grade Glioma Patients.
Xu D; Li P; Zhang C; Shen Y; Cai J; Wei Q; Cao M; Xu Z; Wu D; Wang H; Bi X; Wang B; Li K
Stem Cells Int; 2024; 2024():2062283. PubMed ID: 38229597
[TBL] [Abstract][Full Text] [Related]
7. TGF-β score based on silico analysis can robustly predict prognosis and immunological characteristics in lower-grade glioma: the evidence from multicenter studies.
Zhang W; Yan Z; Zhao F; He Q; Xu H
Recent Pat Anticancer Drug Discov; 2023 Sep; ():. PubMed ID: 37718518
[TBL] [Abstract][Full Text] [Related]
8. Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma.
Wu F; Zhao Z; Chai R; Liu Y; Wang K; Wang Z; Li G; Huang R; Jiang H; Zhang K
Cancer Cell Int; 2018; 18():107. PubMed ID: 30069164
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of necroptosis related gene signature to predict clinical outcomes, immune status and drug sensitivity in lower grade Glioma.
Hu X; Ma Y; Xia Y; Liu B
Heliyon; 2024 Jan; 10(1):e23947. PubMed ID: 38192784
[TBL] [Abstract][Full Text] [Related]
10. An alternative extension of telomeres related prognostic model to predict survival in lower grade glioma.
Cai Y; Guo H; Zhou J; Zhu G; Qu H; Liu L; Shi T; Ge S; Qu Y
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13575-13589. PubMed ID: 37515613
[TBL] [Abstract][Full Text] [Related]
11. Glycolysis‑related lncRNA may be associated with prognosis and immune activity in grade II‑III glioma.
Yang T; Zhang R; Cui Z; Zheng B; Zhu X; Yang X; Huang Q
Oncol Lett; 2024 May; 27(5):238. PubMed ID: 38601183
[TBL] [Abstract][Full Text] [Related]
12. A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma.
Li W; Lv D; Yao J; Chen B; Liu H; Li W; Xu C; Li Z
PLoS One; 2023; 18(9):e0291024. PubMed ID: 37733705
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analyses of m1A regulator-mediated modification patterns determining prognosis in lower-grade glioma (running title: m1A in LGG).
Lei K; Sheng Y; Luo M; Liu J; Gong C; Lv S; Tu W; Ye M; Wu M; Xiao B; Fang H; Luo H; Liu X; Long X; Zhu X; Huang K; Li J
Heliyon; 2024 Mar; 10(6):e27510. PubMed ID: 38510043
[TBL] [Abstract][Full Text] [Related]
14. Oncogene or tumor suppressor? Long noncoding RNAs role in patient's prognosis varies depending on disease type.
Huang Y; Ling A; Pareek S; Huang RS
Transl Res; 2021 Apr; 230():98-110. PubMed ID: 33152534
[TBL] [Abstract][Full Text] [Related]
15. Construction of a Risk Model to Predict the Prognosis and Immunotherapy of Low-Grade Glioma Ground on 7 Ferroptosis-Related Genes.
Sun L; Li B; Wang B; Li J; Li J
Int J Gen Med; 2022; 15():4697-4716. PubMed ID: 35548585
[TBL] [Abstract][Full Text] [Related]
16. Identification of molecular subtypes and a risk model based on inflammation-related genes in patients with low grade glioma.
Long C; Song Y; Pan Y; Wu C
Heliyon; 2023 Dec; 9(12):e22429. PubMed ID: 38046156
[TBL] [Abstract][Full Text] [Related]
17. Interplay of Sphingolipid Metabolism in Predicting Prognosis of GBM Patients: Towards Precision Immunotherapy.
Wang Q; Zheng C; Hou H; Bao X; Tai H; Huang X; Li Z; Li Z; Wang Q; Pan Q; Wang L; Zhou S; Bian Y; Pan Q; Gong A; Xu M
J Cancer; 2024; 15(1):275-292. PubMed ID: 38164288
[No Abstract] [Full Text] [Related]
18. Identification of novel lactate metabolism-related lncRNAs with prognostic value for bladder cancer.
Wang X; Pan J; Guan Q; Ren N; Wang P; Wei M; Li Z
Front Pharmacol; 2023; 14():1215296. PubMed ID: 37781694
[No Abstract] [Full Text] [Related]
19. Ferroptosis-related gene MTF-1 as a novel prognostic biomarker in low-grade glioma and its correlation with immune infiltration.
Li H; Dai X; Zhou L; Nie J; Cheng H; Gao P
Heliyon; 2023 Nov; 9(11):e21159. PubMed ID: 38027604
[TBL] [Abstract][Full Text] [Related]
20. A novel oncolytic virus-based biomarker participates in prognosis and tumor immune infiltration of glioma.
Hao Z; Yin X; Ding R; Chen L; Hao C; Duan H
Front Microbiol; 2023; 14():1249289. PubMed ID: 37808305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
